Skip to main content
. 2020 Feb 25;10:3391. doi: 10.1038/s41598-020-60361-3

Figure 2.

Figure 2

Molecular barcode sequencing sensitively detects the tumor-derived mutations in plasma cell free DNA (cfDNA). Heat map shows the mutation profiles in tumors and plasma cfDNA using both sequencing methods. Samples were collected from 12 patients with biliary-pancreatic (Case #1–4) and non-small cell lung cancers (Case #5–12). Sequencing was performed with non-molecular barcode (Non-MB) and molecular barcode (MB) technologies. Identical mutations in plasma cfDNA corresponding to mutations in tumor samples were detected. Variant allele fraction (%) is shown in each box and is indicated by the graduated color scale from 1% (light blue) to 100% (dark blue). Gray box indicates no identified alterations. Tumor types (CCC, cholangiocarcinoma; GBC, gallbladder cancer; PC, pancreatic cancer, NSCLC, non-small cell lung cancer) were denoted under the case number. Variant with asterisk (*) shows the mutations which are detected by visual inspection of Binary SAM (BAM) files by Ion Reporter Genomic Viewer.